<DOC>
	<DOC>NCT02862561</DOC>
	<brief_summary>Objectives: To evaluate the safety and effectiveness of cell therapy using Precision Cell Immunotherapy to treat Advanced Gastric Cancer. Eligibility: Individuals greater than or equal to 18 years of age and less than or equal to 65 years of age who have been diagnosed with Advanced Gastric Cancer.</brief_summary>
	<brief_title>Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer</brief_title>
	<detailed_description>A total of 40 patients may be enrolled over a period of 1-2 years.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age 18~65 years old, male or female; Life expectancy≥6 months; ECOG score: 03; Advanced Malignancies (gastric cancer) were diagnosed by pathological or clinical physicians; Enough venous channel, no other contraindications to the separation and collection of white blood cells; Laboratory examination: white blood cell≥3 x 10*9/L, blood platelet count≥60 x 10*/L, hemoglobin≥85g/L; lymphocyte count≥15%, total bilirubin≤100 mol/L; ALT and AST less than five times of the normal level; serum creatinine less than 1.5 times of the normal level; Signed informed consent; Women of childbearing age must have evidence of negative pregnancy test and be willing to practice birth control after 2 weeks following the cells transfusion. Expected Overall survival ＜ 6 months; Patients with uncontrolled hypertension (&gt;160/95mmHg), unstable coronary disease (uncontrolled arrhythmias, unstable angina, decompensated congestive heart failure (&gt; Class II, NYHA), or myocardial infarction within 6 months; Other serious diseases: nervous, mental disorders, immune regulatory diseases, metabolic diseases, infectious diseases, etc; Other drugs, or other biological treatment,chemotherapy or radiotherapy are performed within a month; Unable or unwilling to provide informed consent, or fail to comply with the test requirements.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Precision Cell Immunotherapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Advanced Malignancies</keyword>
</DOC>